The popliteal lymph node assay: a tool for predicting drug allergies

Area of Science:

• Immunotoxicology
• Drug Safety Assessment

Background:

• Systemic hypersensitivity to drugs is a significant clinical concern, often undetected in standard toxicity tests.
• Immunological processes and predisposing factors contribute to drug-induced hypersensitivity, necessitating reliable screening methods.

Purpose of the Study:

• To evaluate the popliteal lymph node assay (PLNA) as a screening tool for assessing the immunostimulating and immunosensitizing potential of chemicals.
• To determine the utility of PLNA in predicting drug allergy and hypersensitivity.

Main Methods:

• The popliteal lymph node assay (PLNA) measures lymph node hyperplasia in response to chemical injection.
• Modified PLNA utilizes reporter antigens (TNP-OVA, TNP-Ficoll) to differentiate T cell-dependent and T cell-independent immune responses.
• Assessment includes measuring anamnestic immune reactions and T cell involvement.

Main Results:

• Results from approximately 130 compounds showed good correlation with known immunostimulating potential (autoimmunogenic and allergic).
• No false negatives were detected when chemical metabolism was considered.
• The assay effectively distinguished between sensitizing and non-sensitizing, and inflammatory versus innocent compounds.

Conclusions:

• The PLNA demonstrates a strong correlation with documented immunostimulating potential, suggesting its utility in predicting drug hypersensitivity.
• Further validation is required before the PLNA can be widely recommended for predicting drug allergy.